These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 410646)

  • 1. mu-Chain secretion by peripheral blood lymphocytes in mu-chain disease; functional and ultrastructional characterization of cells associated with mu-chain production.
    Wetter O; Linder KH; Leene W
    Eur J Cancer (1965); 1977 Sep; 13(9):985-92. PubMed ID: 410646
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
    Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
    Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD).
    Wetter O; Drosdziok W; Müller B
    Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive molecular characterization of a heavy chain deposition disease case.
    Bender S; Ayala MV; Javaugue V; Bonaud A; Cogné M; Touchard G; Jaccard A; Bridoux F; Sirac C
    Haematologica; 2018 Nov; 103(11):e557-e560. PubMed ID: 30026336
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicochemical and immunological properties of a mu chain disease protein.
    Mihaesco C; Mihaesco E; Miglierina R; Lamaziere J; Roy JP; Seligmann M
    Immunochemistry; 1976 Jan; 13(1):39-45. PubMed ID: 815173
    [No Abstract]   [Full Text] [Related]  

  • 6. The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain.
    Karasuyama H; Kudo A; Melchers F
    J Exp Med; 1990 Sep; 172(3):969-72. PubMed ID: 2117638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-chain disease. Report of two new cases.
    Brouet JC; Seligmann M; Danon F; Belpomme D; Fine JM
    Arch Intern Med; 1979 Jun; 139(6):672-4. PubMed ID: 109059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on an eleventh case of heavy (Hgamma1) chain disease--biosynthetic studies.
    Arima T; Miyamoto-Sudo C; Hiroata M; Tanigawa T; Tsuboi S
    Acta Med Okayama; 1975 Jun; 29(3):225-31. PubMed ID: 127516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heavy chain diseases].
    Seligmann M
    Acquis Med Recent; 1978; ():151-61. PubMed ID: 120668
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles of heavy and light chains in IgM polymerization.
    Bornemann KD; Brewer JW; Beck-Engeser GB; Corley RB; Haas IG; Jäck HM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4912-6. PubMed ID: 7761423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of the cell-surface expression of immunoglobulin mu chain without light chain in human B lymphocytes.
    Pollok BA; Anker R; Eldridge P; Hendershot L; Levitt D
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9199-203. PubMed ID: 3122216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Liver Epithelial Cell-derived Ig Expression in μ chain-deficient mice.
    Shao W; Zhang C; Liu E; Zhang L; Ma J; Zhu Z; Gong X; Qin Z; Qiu X
    Sci Rep; 2016 Mar; 6():23669. PubMed ID: 27020674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and mu-heavy chain fragment in the serum.
    Pruzanski W; Hasselback R; Katz A; Parr DM
    Am J Med; 1978 Aug; 65(2):334-41. PubMed ID: 99035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heavy chain disease: humoral and cellular findings in six patients with mu chain disease (author's transl)].
    Wetter O; Schmidt CG; Linder KH; Leene W
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):207-23. PubMed ID: 112103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a C-terminal tyrosine residue in human and mouse B-lymphocyte membrane mu chains.
    McIlhinney RA; Richardson NE; Feinstein A
    Nature; 1978 Apr; 272(5653):555-7. PubMed ID: 99661
    [No Abstract]   [Full Text] [Related]  

  • 17. Allelic exclusion in transgenic mice expressing a heavy chain disease-like human mu protein.
    Corcos D; Iglesias A; Dunda O; Bucchini D; Jami J
    Eur J Immunol; 1991 Nov; 21(11):2711-6. PubMed ID: 1936120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on mu chain purification and preparation of anti-mu chain serum.
    Lu ZM; Zhang DH; Wang QH; Li XM; Qin YF; Qian ZF; Huang DS
    Chin Med J (Engl); 1985 Mar; 98(3):181-6. PubMed ID: 3924510
    [No Abstract]   [Full Text] [Related]  

  • 19. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
    Liapis H; Papadakis I; Nakopoulou L
    Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disease of heavy chains mu (new forms of paraproteinemic hemoblastoses)].
    Andreeva NE; Antipova LG; Chernokhvostova EV; Batalova TN
    Ter Arkh; 1976; 48(8):10-5. PubMed ID: 828779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.